2,603 results on '"Jaffe, Elaine S"'
Search Results
2. Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study)
3. Breast Implant Associated Anaplastic Large Cell Lymphoma: Evidence-Based Consensus Conference Statement From The American Association of Plastic Surgeons
4. Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients
5. Primary large B-cell lymphomas of immune-privileged sites
6. Tissue Eosinophilia in B-cell Lymphoma: An Underrecognized Phenomenon
7. Advances in the Classification of Myeloid and Lymphoid Neoplasms
8. Follicular lymphoma and marginal zone lymphoma: how many diseases?
9. Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities
10. New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders
11. How I Diagnose Angioimmunoblastic T-Cell Lymphoma
12. Evolution of Lymphoma Diagnosis in the Era of Personalized Medicine: A Marriage of Pathology and Genomics for Clinical Practice
13. List Of Contributors
14. Lymphomas
15. Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial
16. CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma
17. Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma
18. CSF1R/CD115 is a Helpful Marker for the Distinction of Florid Dermatopathic Lymphadenopathy From Langerhans Cell Neoplasms
19. B- and T-/NK-Cell Lymphomas in the 2022 International Consensus Classification of Mature Lymphoid Neoplasms and Comparison with the WHO Fifth Edition
20. Peripheral T‐cell lymphomas expressing CD30 and CD15 expand the spectrum of anaplastic large cell lymphoma, ALK‐negative
21. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
22. DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS
23. A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile
24. Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma
25. Overlapping Features of Primary Cutaneous Marginal Zone Lymphoproliferative Disorder and Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder: A Diagnostic Challenge Examined by Genomic Analysis
26. Lymphoma Classifications, How to Develop a Future Unified Taxonomy.
27. B Lymphoblastic Leukemia/Lymphoma With Burkitt-like Morphology and IGH/MYC Rearrangement
28. Next-generation sequencing–based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCL
29. Response to “The WHO classification of haematolymphoid tumours” (Editorial)
30. Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases
31. The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy
32. Motive and opportunity: MYCrearrangements in high-grade B-cell lymphoma with MYCand BCL2rearrangements (an LLMPP study)
33. Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease
34. Diagnostic utility of STAT6YE361 expression in classical Hodgkin lymphoma and related entities
35. Navigating the cutaneous B-cell lymphomas: avoiding the rocky shoals
36. Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements
37. Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry
38. Genomic characterization of diffuse large B-cell lymphoma transformation of nodular lymphocyte-predominant Hodgkin lymphoma
39. Novel markers in pediatric-type follicular lymphoma
40. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas
41. Viral, immunologic, and clinical features of primary effusion lymphoma
42. CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphoma
43. Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study
44. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
45. Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?
46. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations
47. POSTER: ABCL-187 Phase 2 Response-Adapted Study of Ibrutinib With Temozolomide, Etoposide, Liposomal Doxorubicin, Dexamethasone, Rituximab (TEDDI-R) for Secondary CNS Lymphoma
48. ABCL-187 Phase 2 Response-Adapted Study of Ibrutinib With Temozolomide, Etoposide, Liposomal Doxorubicin, Dexamethasone, Rituximab (TEDDI-R) for Secondary CNS Lymphoma
49. Follicular lymphoma involving the synovium in rheumatoid arthritis
50. An AID to follicular lymphoma transformation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.